These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32735004)

  • 1. A cell membrane vehicle co-delivering sorafenib and doxorubicin remodel the tumor microenvironment and enhance immunotherapy by inducing immunogenic cell death in lung cancer cells.
    Wan J; Wang J; Zhou M; Rao Z; Ling X
    J Mater Chem B; 2020 Sep; 8(34):7755-7765. PubMed ID: 32735004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy.
    Wang JY; Song YQ; Peng J; Luo HL
    ACS Omega; 2020 Sep; 5(36):22840-22846. PubMed ID: 32954132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic Therapy in Combination with Sorafenib for Enhanced Immunotherapy of Lung Cancer.
    Guo T; Lin W; Chen W; Huang Y; Zhu L; Pan X
    J Biomed Nanotechnol; 2020 Aug; 16(8):1219-1228. PubMed ID: 33397552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transformable prodrug nanoplatform
    Yang W; Yi J; Zhu R; Guo Y; Zhang K; Cao Y; Li X; Zhang J; Zhang Z; Li Y; Chen X
    Theranostics; 2023; 13(6):1906-1920. PubMed ID: 37064869
    [No Abstract]   [Full Text] [Related]  

  • 5. Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment.
    Wen Y; Chen X; Zhu X; Gong Y; Yuan G; Qin X; Liu J
    ACS Appl Mater Interfaces; 2019 Nov; 11(46):43393-43408. PubMed ID: 31701733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An ultrasound-activated nanoplatform remodels tumor microenvironment through diverse cell death induction for improved immunotherapy.
    Ma J; Yuan H; Zhang J; Sun X; Yi L; Li W; Li Z; Fu C; Zheng L; Xu X; Wang X; Wang F; Yin D; Yuan J; Xu C; Li Z; Peng X; Wang J
    J Control Release; 2024 Jun; 370():501-515. PubMed ID: 38703950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA nanodevice as a multi-module co-delivery platform for combination cancer immunotherapy.
    Nie C; Ye J; Jiang JH; Chu X
    J Colloid Interface Sci; 2024 Aug; 667():1-11. PubMed ID: 38615618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acidic microenvironment responsive polymeric MOF-based nanoparticles induce immunogenic cell death for combined cancer therapy.
    Zhang X; Lu Y; Jia D; Qiu W; Ma X; Zhang X; Xu Z; Wen F
    J Nanobiotechnology; 2021 Dec; 19(1):455. PubMed ID: 34963499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer.
    Li S; Wang S; Zhang A; Luo L; Song J; Wei G; Fang Z
    Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38391053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repolarizing Tumor-Associated Macrophages and inducing immunogenic cell Death: A targeted liposomal strategy to boost cancer immunotherapy.
    Li C; Wang L; Li Z; Li Z; Zhang K; Cao L; Wang Z; Shen C; Chen L
    Int J Pharm; 2024 Feb; 651():123729. PubMed ID: 38142016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
    Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S
    J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
    Zang X; Song J; Yi X; Piyu J
    J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death.
    Phung CD; Nguyen HT; Choi JY; Pham TT; Acharya S; Timilshina M; Chang JH; Kim JH; Jeong JH; Ku SK; Choi HG; Yong CS; Kim JO
    J Control Release; 2019 Dec; 315():126-138. PubMed ID: 31672625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
    Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
    Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy.
    Ma B; Ma Y; Deng B; Xiao P; Huang P; Wang D; Liu L
    J Nanobiotechnology; 2023 May; 21(1):171. PubMed ID: 37237292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing TNBC Chemo-immunotherapy via combination reprogramming tumor immune microenvironment with Immunogenic Cell Death.
    Wu S; Liu D; Li W; Song B; Chen C; Chen D; Hu H
    Int J Pharm; 2021 Apr; 598():120333. PubMed ID: 33540008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β inhibition combined with cytotoxic nanomedicine normalizes triple negative breast cancer microenvironment towards anti-tumor immunity.
    Panagi M; Voutouri C; Mpekris F; Papageorgis P; Martin MR; Martin JD; Demetriou P; Pierides C; Polydorou C; Stylianou A; Louca M; Koumas L; Costeas P; Kataoka K; Cabral H; Stylianopoulos T
    Theranostics; 2020; 10(4):1910-1922. PubMed ID: 32042344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
    Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
    Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem Chemoimmunotherapy by a Cascade-Responsive Molecular Prodrug.
    Yang Z; Luo X; Lin Y; Huang J; Lin H; Gao J
    ACS Chem Biol; 2022 Apr; 17(4):762-767. PubMed ID: 35285234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.